8-K: Axe Compute Rebrands, Pivots to AI Infrastructure

Axe Compute Inc., formerly Predictive Oncology, announced a strategic pivot into high-performance AI infrastructure and an increase in CEO Raymond F. Vennare's compensation.

Summary

• Axe Compute Inc. (formerly Predictive Oncology Inc.) filed an 8-K report on December 12, 2025, detailing an amendment to its CEO's employment agreement and a corporate rebranding.
• The company changed its name to Axe Compute Inc. and its common stock began trading on Nasdaq under the ticker symbol AGPU on December 12, 2025.
• Raymond F. Vennare, Chief Executive Officer, received an amendment to his employment agreement, increasing his annual base salary from $525,000 to $575,000, effective retroactively to November 1, 2025.
• Mr. Vennare is now eligible for an annual target bonus of 50% of his current base salary (currently $287,500) for 2025 performance, payable by March 31, 2026, with provisions for early termination.
• He will also be granted 20,000 restricted stock units (RSUs) under the company's 2024 Equity Incentive Plan, vesting in full on January 1, 2026, subject to continuous employment.
• Axe Compute plans to expand its business into high-performance enterprise AI infrastructure, while continuing its AI-driven drug discovery business.
• The company intends to utilize its ATH on the Aethir network to secure GPU capacity and services, aiming to address the rising global demand for scalable compute capacity for enterprise AI workloads.

Sentiment

Score: 8

Explanation: The filing indicates a strong positive strategic shift into a high-growth industry (AI infrastructure) with clear plans for execution, alongside increased executive compensation, suggesting confidence in future performance. While new ventures carry inherent risks, the overall tone and strategic direction are highly optimistic.

Positives

• CEO Raymond F. Vennare's annual base salary increased by $50,000 to $575,000, effective retroactively to November 1, 2025.
• Mr. Vennare is eligible for a significant annual target bonus of 50% of his base salary ($287,500) for 2025 performance.
• The grant of 20,000 restricted stock units to the CEO provides additional incentive and aligns management interests with shareholder value.
• The strategic pivot into high-performance enterprise AI infrastructure positions the company in a rapidly growing and high-demand market.
• The company's plan to leverage the Aethir network for GPU capacity aims to provide predictable and scalable compute solutions, addressing a critical bottleneck in AI progress.

Risks

• Failing to realize the anticipated benefits of the company's digital asset treasury strategy.
• Economic conditions and their potential impact on business operations and financial performance.
• Fluctuations in the market price of ATH and other digital assets, which could affect revenue and asset value.
• The impact of the evolving regulatory environment on the company's new business model and digital asset strategy.
• The ability of the company to successfully execute its digital asset treasury strategy and the implications for shareholders and the core drug discovery business.
• The ability of the Aethir network to perform in a manner consistent with projections and meet service level agreements.
• The ability for the company to generate revenue on the Aethir network as anticipated.
• The success, timing, and implementation of services to be provided by the Aethir network to the company.
• The ability for the company to onboard and maintain enterprise and other clients to provide computing services.
• The ability for the company to successfully implement planned commercial activities in the new AI infrastructure sector.
• Market adoption of the company's new products and services in the competitive AI infrastructure landscape.
• Risks inherent in projecting future performance based on limited historical data, especially for a new business segment.
• Risks related to the success of collaboration arrangements, commercialization activities, and product sales levels by collaboration partners in the drug discovery business.

Future Outlook

Axe Compute plans to expand significantly into high-performance enterprise AI infrastructure, leveraging the Aethir network to provide scalable GPU capacity and services. The company aims to operate as an active infrastructure provider, acquiring rights to digital assets and deploying them to enterprise clients under service contracts, generating revenue from token rewards and service margins. It will continue its AI-driven drug discovery business and may explore other digital asset categories as its operating model matures.

Management Comments

• Management believes the bottleneck to AI progress is increasingly infrastructure, not algorithms, driving the strategic pivot.
• The company believes it can utilize its ATH on the Aethir network to secure GPU capacity and services to support compute demand.
• Axe Compute intends to monetize access to the Aethir network for enterprise buyers requiring guaranteed capacity, service-level agreements, and a counterparty within traditional corporate and regulatory structures.
• The company anticipates sourcing infrastructure at competitive rates and providing reliable, predictable access to high-capacity compute through the Aethir network.

Industry Context

The announcement comes amidst a global surge in demand for AI infrastructure, with GPU procurement timelines extending to 40-52 weeks and enterprise spending on AI cloud services projected to exceed $400 billion in 2025. Centralized cloud providers face capacity constraints, creating multi-month deployment queues. Axe Compute aims to capitalize on this 'Infrastructure Gap' by providing dedicated GPU capacity through a decentralized network.

Comparison to Industry Standards

• Axe Compute positions itself distinctly from hyperscalers like AWS, which offer a broad range of services, and model developers like OpenAI, which focus on model capabilities.
• The company plans to operate in the space between these entities, utilizing the Aethir network to provide specific, dedicated GPU capacity that AI-native companies require when traditional cloud queues are too long or building internal infrastructure is too slow.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential for significant growth and new revenue streams from the strategic pivot into AI infrastructure, but also exposure to new risks associated with this venture and digital assets.
• CEO (Raymond F. Vennare): Directly benefits from increased base salary, target bonus eligibility, and restricted stock unit grant, aligning his incentives with company performance.
• Employees: The strategic expansion into AI infrastructure may create new opportunities and roles within the company.
• Customers: New enterprise clients will gain access to dedicated GPU capacity and services through Axe Compute's leveraging of the Aethir network.

Next Steps

• Initial deployments of AI infrastructure capacity are expected to come online.
• Expansion of the enterprise client base for AI compute services.
• Potential exploration into other digital asset categories beyond compute infrastructure as the operating model matures.

Key Dates

Recommendation

The company is undergoing a significant strategic pivot into the high-demand AI infrastructure market, which presents substantial growth opportunities. However, this is a new venture with inherent risks related to execution, market adoption, and the volatile nature of digital assets and the evolving regulatory environment. While the increased CEO compensation signals confidence, investors should 'hold' to observe the initial success of this strategic shift and the company's ability to mitigate the associated risks before making further investment decisions.

Keywords

Axe Compute, Predictive Oncology, AI infrastructure, GPU capacity, Aethir network, NASDAQ, AGPU, CEO compensation, restricted stock units, corporate rebranding, digital assets, drug discovery